Strict regulations have prevented continental U.S. beekeepers from participating in the lucrative organic honey market, but new findings could provide evidence to open organic markets to U.S. producers.
An overactive immune response in the brain may play a role in Dravet syndrome, a rare and severe genetic epilepsy that typically begins in infancy, according to Weill Cornell Medicine researchers.
A new way to measure comorbidity can be used to accurately predict a patient’s risk of hospitalization and future healthcare costs across a population.
As psychedelic drugs gain more support from the medical community as a potential treatment for severe depression, Cornell researchers are making crucial discoveries that explain how compounds such as psilocybin work on the brain.
Across 37 counties, Cornell Cooperative Extension master gardeners are growing and evaluating select vegetables to find what grows best in New York state.
Weill Cornell Medicine has received a three-year, $2.5 million grant from the Department of Defense to develop therapies with fewer side effects for triple-negative breast cancer, one of the most aggressive and difficult-to-treat breast cancers.
